A clinical trial to learn about the effects of INR731 alone or with an androgen receptor pathway inhibitor (ARPI) in men with prostate cancer

Status

Not yet recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2025-524080-20-00

Enrollment

Registered

2026-08-17

Start date

Unknown

Completion date

Unknown

Last updated

2026-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metastatic castration resistant prostate cancer

None listed

Sex/Gender

Male

Age

18 Years to No maximum

None listed

Source: EU CTIS · Data processed: Aug 18, 2026